Dr Howard Weiner from the Harvard Medical School and Tiziana Life Sciences PLC’s (LON:TILS) (NASDAQ:TLSA) scientific advisory board chairman speaks to Proactive’s Andrew Scott following the news they’ve completed the clinical trial of its nasally administered Foralumab for the treatment…
A strain of virus SARS-CoV-2 that was isolated from India has revealed a mutation, according to a non-peer reviewed study published in bioRxiv. According to researchers, this can capsize global vaccine development efforts. The strain was isolated from one of…